• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Post-COVID impairment of T cell responses to community-acquired pathogens can be modified by activating cellular metabolism

tetano

Editor, Senior Moderator
PLoS Pathog


. 2026 Jul 30;22(7):e1013860.
doi: 10.1371/journal.ppat.1013860. Online ahead of print.
Post-COVID impairment of T cell responses to community-acquired pathogens can be modified by activating cellular metabolism

Daniel D Carroll[SUP] 1 [/SUP], Kamacay Cira[SUP] 1 2 [/SUP], Jack Archer[SUP] 1 [/SUP], Jason Shapiro[SUP] 3 [/SUP], Hardik Shah[SUP] 4 [/SUP], Ue-Yu Pen[SUP] 5 [/SUP], David Tieri[SUP] 3 [/SUP], Lucia Leonor[SUP] 6 [/SUP], Neda D Roofchayee[SUP] 6 [/SUP], Samantha S Yee[SUP] 1 [/SUP], Marc Wahab[SUP] 1 [/SUP], Igor J Koralnik[SUP] 6 [/SUP], John C Alverdy[SUP] 1 [/SUP], Arjun S Raman[SUP] 5 [/SUP], Lavanya Visvabharathy[SUP] 1 [/SUP]


Affiliations
Free article Abstract

Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic, though underlying causes remain elusive. Potential causes ranging from increased hospitalizations during the pandemic or greater use of antibiotics have been proposed, but precisely why rates remain high today remains unknown. Here, we demonstrate that decreased mitochondrial function in antigen-specific T cells post-COVID may contribute to higher infection susceptibility by metabolically immobilizing T cell responses. Using donor-matched peripheral blood samples from 31 COVID-naïve individuals who subsequently contracted COVID-19, we tracked how influenza A (IAV), Staphylococcus aureus (SA), and Varicella-zoster virus (VZV)-stimulated T cell responses were impacted by SARS-CoV-2 infection. Post-COVID CD4 memory T cells exhibited decreased activation- and increased mitochondrial redox-related gene expression. Despite this, mitochondrial flux and reactive oxygen species production were functionally limited in post-COVID antigen-specific T cells after stimulation with IAV, SA, and VZV. Post-COVID plasma was depleted in carnitine and TCA cycle species important for activating fatty acid oxidation, and this correlated with a disordered relationship between memory T cell mobilization of glycolysis, fatty acid metabolism, and oxidative phosphorylation pathways. Metabolic perturbations ultimately resulted in diminished use of catabolic, energy-generating pathways including glycolysis and fatty acid oxidation in antigen-specific T cells. Activating mitochondrial function with metformin and ubiquinol partially rescued the post-COVID decline in T cell catabolism. Collectively, these findings indicate that COVID-19 infection may inhibit T cell metabolism upon exposure to commonly encountered pathogens, which can be partly corrected with commonly available medications that activate mitochondrial metabolism. Our findings may have significant implications for the clinical care of immunologically vulnerable populations in the post-pandemic era.


 
Back
Top